Cathie Wood Dumps DraftKings and Loads Up on CRISPR Therapeutics Stock
Photo: CoinCentral
TLDR ARK sold 397,016 DraftKings shares on Oct. 9, worth about $7.89 million, through its ARKW and ARKF funds. ARK also sold shares of CareDx, SpaceX, AMD, Alphabet, Shopify and Robinhood. The ARKG fund added CRISPR Therapeutics, Intellia, Beam Therapeutics and Nurix Therapeutics. ARK also bought Guardant Health, Kymera, Compass Pathways, Alamar Biosciences and Freenome. ARKG closed up more than 4% on Friday. Cathie Wood’s ARK Invest published its daily trades for Friday, Oct. 9, 2026. The trades covered several of its exchange-traded funds. ARK sold a number of well-known technology and growth names.
Source: CoinCentral
